Geographic Variation in Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccine Introduction in the United States

被引:67
作者
Rosen, Jennifer B. [1 ,2 ]
Thomas, Ann R. [3 ]
Lexau, Catherine A. [4 ]
Reingold, Art [5 ]
Hadler, Jim L. [6 ]
Harrison, Lee H. [7 ]
Bennett, Nancy M. [8 ]
Schaffner, William [9 ]
Farley, Monica M. [10 ,11 ]
Beall, Bernard W. [1 ]
Moore, Matt R. [1 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA USA
[2] Off Workforce & Career Dev, Epidem Intelligence Serv, Atlanta, GA USA
[3] Oregon Publ Hlth Div, Portland, OR USA
[4] Minnesota Dept Hlth, St Paul, MN USA
[5] Calif Emerging Infect Program, Oakland, CA USA
[6] Yale Univ, Sch Publ Hlth, Connecticut Emerging Infect Program, New Haven, CT USA
[7] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[8] Univ Rochester, Sch Med & Dent, Ctr Community Hlth, Rochester, NY USA
[9] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA
[10] Emory Univ, Dept Med, Sch Med, Georgia Emerging Infect Program, Atlanta, GA 30322 USA
[11] VA Med Ctr, Atlanta, GA USA
关键词
STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; CHANGING EPIDEMIOLOGY; SEROTYPE; CHILDREN; ERA; IMMUNIZATION; SURVEILLANCE; INFECTION; EMERGENCE;
D O I
10.1093/cid/cir326
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Rates of invasive pneumococcal disease (IPD) varied among the United States before pneumococcal conjugate vaccine (PCV7) introduction. We compared trends in IPD rates among diverse US sites over 10 years since PCV7 introduction. Methods. Patients with IPD of all ages were identified through active population and laboratory-based surveillance in 8 geographic areas under continuous surveillance during 1998-2009. Isolates were serotyped. IPD incidence rates and percent changes were calculated by site, serotype group, age, and year. Results. Reductions in rates of IPD ranged, by site, from 19 to 29.9 cases per 100,000 population during 1998-1999 to 11.2-18.0 cases per 100,000 population during 2009 (rate reduction, 5.1-15.3 cases per 100,000 population). Reductions in IPD rates among children aged < 5 years ranged from 35.7 to 117.2 cases per 100,000 population across the sites. Reductions in rates of IPD due to PCV7 serotypes were seen in all age groups at all sites, ranging from 12 to 21.4 cases per 100,000 population during 1998-1999 to < 2 cases per 100,000 population during 2009 (92%-98% reductions). Serotype 19A rates ranged from 0.4 to 1.5 cases per 100,000 population during 1998-1999 to 1.3 to 3.4 cases per 100,000 population during 2009 (rate difference, 0.9-2.8 cases per 100,000 population); modest increases were observed for most age groups across the sites. Rates of IPD due to all other serotypes ranged from 6.3 to 10.3 cases per 100,000 population during 1998-1999 to 8.3-13.6 cases per 100,000 population during 2009 (rate difference, -0.4 to 5.7 cases per 100,000 population). Across the sites, the greatest rate increases were seen in the 50-64 and > 65 year age groups. Conclusions. Reductions in IPD due to vaccine serotypes were consistent across sites. Changes in serotype 19A and all other serotypes were variable. Although relative increases in non-vaccine type serotypes were large in some sites, absolute rate increases were small.
引用
收藏
页码:137 / 143
页数:7
相关论文
共 23 条
[1]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[2]   Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente [J].
Black, S ;
Shinefield, H ;
Baxter, R ;
Austrian, R ;
Bracken, L ;
Hansen, J ;
Lewis, E ;
Fireman, B .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (06) :485-489
[3]   Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the Intermountain West:: Emergence of nonvaccine serogroups [J].
Byington, CL ;
Samore, MH ;
Stoddard, GJ ;
Barlow, S ;
Daly, J ;
Korgenski, K ;
Firth, S ;
Glover, D ;
Jensen, J ;
Mason, EO ;
Shutt, CK ;
Pavia, AT .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (01) :21-29
[4]  
Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893
[5]  
Dagan R, 2007, 47 INT C ANT CHEM
[6]   Effects of the 7-valent pneumococcal conjugate vaccine on US levofloxacin-resistant streptococcus pneumoniae [J].
Davies, Todd A. ;
Yee, Y. Cheung ;
Bush, Karen ;
Sahm, Dan ;
Evangelista, Alan ;
Goldschmidt, Raul .
MICROBIAL DRUG RESISTANCE, 2008, 14 (03) :187-196
[7]   Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections [J].
Flannery, B ;
Schrag, S ;
Bennett, NA ;
Lynfield, R ;
Harrison, LH ;
Reingold, A ;
Cieslak, PR ;
Hadler, J ;
Farley, MM ;
Facklam, RR ;
Zell, ER ;
Whitney, CG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (18) :2197-2203
[8]   Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: Serotype and antimicrobial resistance patterns in the United States [J].
Fry, AM ;
Facklam, RR ;
Whitney, CG ;
Plikaytis, BD ;
Schuchat, A .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (05) :643-652
[9]   The association between antibiotic use in the community and nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae in Bedouin children [J].
Greenberg, David ;
Givon-Lavi, Noga ;
Sharf, Amir Z. ;
Vardy, Daniel ;
Dagan, Andron .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (09) :776-782
[10]   Invasive pneumococcal infection in Baltimore, Md -: Implications for immunization policy [J].
Harrison, LH ;
Dwyer, DM ;
Billmann, L ;
Kolczak, MS ;
Schuchat, A .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (01) :89-94